NCT01761526View on ClinicalTrials.gov

Study to Evaluate the Pharmacokinetics (PK), Safety, Tolerability of Single-Dose Transdermal Rotigotine in Japanese and Caucasian Healthy Male / Female Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 31, 2002

Primary Completion Date

October 31, 2002

Study Completion Date

December 31, 2002

Conditions
Healthy
Interventions
DRUG

Rotigotine transdermal patch

Rotigotine transdermal patch, single-dose application over 24 hours 2 mg /24 hours (10 cm2)

Trial Locations (1)

Unknown

01, Neuss

All Listed Sponsors
collaborator

Schwarz BioSciences GmbH

UNKNOWN

collaborator

Alfred-Nobel-Str. 10

UNKNOWN

collaborator

40789 Monheim am Rhein

UNKNOWN

lead

UCB BIOSCIENCES GmbH

INDUSTRY

NCT01761526 - Study to Evaluate the Pharmacokinetics (PK), Safety, Tolerability of Single-Dose Transdermal Rotigotine in Japanese and Caucasian Healthy Male / Female Subjects | Biotech Hunter | Biotech Hunter